Incidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study
Lykke Sylow, Mia Klinten Grand, Annika von Heymann, Frederik Persson, Volkert Siersma, Margit Kriegbaum, Christen Lykkegaard Andersen, Christoffer Johansen
Abstract
For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer on<br/>overall survival.
Topics & Concepts
MedicineDanishIncidence (geometry)Type 2 diabetesDiabetes mellitusCohort studyCohortCancerInternal medicinePediatricsEndocrinologyLinguisticsOpticsPhilosophyPhysicsMetabolism, Diabetes, and CancerCancer Risks and FactorsNutrition and Health in Aging